Lilly says Cialis is gaining on Viagra

Share this article:
Eli Lilly said Cialis is gaining market share from the top-selling erectile dysfunction (ED) drug, Pfizer’s Viagra. Cialis has gained more than 3% of global market share between July 2005 and July 2006, Lilly said during a presentation to analysts. Sales of Cialis continue to grow in most markets around the globe, including the US, Europe and Latin America. Cialis is on track to be the No. 1 ED drug worldwide -- excluding the US -- by next year, Lilly said. Viagra had 49.3% of the global market as of July, while Cialis had 35.5%, Lilly said. Third-place Levitra, made by GlaxoSmithKline, had about 15.3% of the market. Lilly did not make any claims for overtaking Viagra inside the US, where Viagra holds 58% of the market, compared with 25% for Cialis, Worldwide, Cialis sales are expected to top $1 billion in 2007, which would make it one of Lilly's top five drugs. Cialis is a top-selling ED drug in 17 countries, including France, where it is commonly referred to as "le weekender." Lilly will launch Cialis next year in Japan. Lilly is buying its Cialis marketing partner, Seattle-based Icos, for about $2.1 billion. Cialis' patent does not expire until 2017.
Share this article:

Email Newsletters

More in News

Five things for Pharma Marketers to know: Wednesday, August 27

Five things for Pharma Marketers to know: Wednesday, ...

Allergan sets a shareholder voting date, Novo describes the types of acquisitions it will consider, and the AstraZeneca-Pfizer talks can now reopen.

Eli Lilly and BI's Jardiance hits shelves

Eli Lilly and BI's Jardiance hits shelves

The new SGLT-2 inhibitor is on shelves less than a month after FDA approval.

PhRMA Urges Court to Reject Off-Label Promotion Case

PhRMA Urges Court to Reject Off-Label Promotion Case

The Pharmaceutical Research and Manufacturers of America (PhRMA) says a California federal court should dismiss a whistleblower's False Claims Act suit against three drug companies on First Amendment grounds